Mereo BioPharma Cash Flow Statement (2021-2026) | MREO

Cash Flow Statement Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -12.08M-1.75M-6.53M-10.17M-8.95M-12.26M-15.00M-7.05M-12.89M-14.62M-7.02M-7.35M-6.72M
Depreciation and Depletion (Quarter) 0.04M0.10M0.10M0.04M0.04M0.10M0.10M0.04M0.04M0.10M0.10M0.08M0.04M
Share-based Compensation (Quarter) 1.64M0.94M1.53M0.81M2.05M2.09M1.74M1.51M2.28M2.06M1.71M1.54M1.60M
Gains from Sales and Divestitures (Quarter) 0.50M0.14M0.80M1.34M1.34M
Gains from Investment Securities (Quarter) 2.59M1.97M0.04M-0.48M0.44M0.36M0.13M0.44M-2.33M-0.42M1.98M0.12M-0.29M0.27M
Non-cash Items (Quarter) 0.00M1.17M17.35M18.98M6.96M10.05M
Cash from Operations (Quarter) -9.25M-7.75M2.66M-6.79M-7.99M-7.90M-7.52M-9.42M-8.33M-7.65M-7.31M-7.68M-4.31M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.12M0.05M0.11M0.21M0.11M0.11M0.11M0.11M0.13M0.10M0.17M0.13M0.13M
Depreciation & Amortization (CF) (Quarter) 0.04M0.10M0.10M0.04M0.04M0.10M0.10M0.04M0.04M0.10M0.10M0.08M0.04M
Change in Working Capital
Change in Account Payables (Quarter) 0.81M-2.31M-0.76M0.99M0.13M0.24M-1.06M0.84M0.36M-1.95M-0.24M0.45M1.96M
Change in Accured Expenses (Quarter) -3.10M4.25M-0.15M-1.71M-2.94M3.25M-0.79M-0.71M-1.39M1.93M-0.67M-2.26M0.23M
Investing Activities
Capital Expenditures (Quarter) 0.02M
Change in Intangibles (Quarter) 0.42M0.70M-0.00M0.30M0.30M
Cash from Investing Activities (Quarter) -0.42M-0.70M0.00M-0.32M0.30M-0.30M
Financing Activities
Other financing activities (Quarter) 1.00M0.59M0.04M0.07M0.13M
Change in Capital Stock
Shares Issued (Quarter) 11.51M47.00M0.49M-0.49M0.49M
Misc.
Cash from Financing Activities (Quarter) 7.91M46.78M-0.59M-0.04M0.42M-0.13M0.04M
Exchange Rate Effect (Quarter) 1.29M0.85M-1.00M1.68M-0.07M-0.11M1.20M-1.26M0.91M1.43M-0.42M-0.06M-0.16M
Change in Cash (Quarter) -9.67M-7.69M11.70M-5.11M-8.69M38.88M-8.11M-9.46M-8.23M-7.79M-7.01M-7.64M-4.61M
Free Cash Flow (Quarter) -9.25M-7.75M2.66M-6.79M-7.99M-7.90M-7.52M-9.42M-8.35M-7.65M-7.31M-7.68M-4.31M
Net Cash Flow (Quarter) -9.67M-7.75M10.56M-6.79M-8.69M38.88M-8.11M-9.46M-8.23M-7.79M-7.01M-7.64M-4.61M